Clinical Trial Update: A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update demonstrating hair and scalp benefits of Duobrii in scalp psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Drugs mentioned

• Duobrii (halobetasol propionate and tazarotene)

Snippet

Sponsor: Dermatology Consulting Services, PLLC | Conditions: Scalp Psoriasis | Phase 4 | Status: COMPLETED